These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 3513138)

  • 21. Mexiletine for refractory-ventricular arrhythmias: results using serial electrophysiologic testing.
    DiMarco JP; Garan H; Ruskin JN
    Am J Cardiol; 1981 Jan; 47(1):131-8. PubMed ID: 7457398
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lidocaine, mexiletine and propafenone in the treatment of arrhythmias complicating myocardial infarction. A case report.
    Aguglia F; Gnecchi M; De Marzio P
    Int J Cardiol; 1985 Mar; 7(3):303-6. PubMed ID: 2579918
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The interaction of mexiletine with other cardiovascular drugs.
    Bigger JT
    Am Heart J; 1984 May; 107(5 Pt 2):1079-85. PubMed ID: 6720533
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mexiletine. Use in control of chronic drug-resistant ventricular arrhythmia.
    Abinader EG; Cooper M
    JAMA; 1979 Jul; 242(4):337-9. PubMed ID: 448936
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term oral antiarrhythmic therapy with mexiletine.
    Campbell NP; Pantridge JF; Adgey AA
    Br Heart J; 1978 Jul; 40(7):796-801. PubMed ID: 687477
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Comparative study of the anti-arrhythmic activity of mexiletine and lidocaine in ventricular hyperkinetic arrhythmias].
    Rolli A; Bonatti V; Finardi A; Favaro L; Botti G
    G Ital Cardiol; 1981; 11(4):468-76. PubMed ID: 6169578
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetics and the antiarrhythmic effect of mexiletine in patients with chronic ventricular arrhythmias.
    Ohashi K; Ebihara A; Hashimoto T; Hosoda S; Kondo K; Oka T
    Arzneimittelforschung; 1984; 34(4):503-7. PubMed ID: 6540110
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Anti-arrhythmic efficacy of the amiodarone-mexiletine combination in the treatment of resistant complex ventricular arrhythmias].
    Purcaro A; Massacci C; Curzi G; Pigini G; Costantini C; Bilancini A; Blandini A
    G Ital Cardiol; 1986 May; 16(5):417-26. PubMed ID: 3732727
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative trial of mexiletine and lignocaine in the treatment of early ventricular tachyarrhythmias after acute myocardial infarction.
    Horowitz JD; Anavekar SN; Morris PM; Goble AJ; Doyle AE; Louis WJ
    J Cardiovasc Pharmacol; 1981; 3(3):409-19. PubMed ID: 6168823
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of oral mexiletine on left and right ventricular function.
    Stein J; Podrid P; Lown B
    Am J Cardiol; 1984 Sep; 54(6):575-8. PubMed ID: 6475776
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of disopyramide and mexiletine used alone and in combination for ventricular arrhythmias in patients with and without overt heart disease.
    Tanabe T; Takahashi K; Yoshioka K; Goto Y
    Int J Cardiol; 1991 Sep; 32(3):303-12. PubMed ID: 1724233
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Antiarrhythmic treatment with mexiletine in acute myocardial infarction (author's transl)].
    Codecà L; Gruppillo P; Padovan GC; Masoni C; Masoni A
    G Ital Cardiol; 1981; 11(4):477-80. PubMed ID: 7286520
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mexiletine for recurring ventricular arrhythmias: assessment by long-term electrocardiographic recordings and sequential electrophysiologic studies.
    Flaker GC; Madigan NP; Alpert MA; Moser SA
    Am Heart J; 1984 Sep; 108(3 Pt 1):490-5. PubMed ID: 6475711
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antiarrhythmic agents for chronic ventricular arrhythmias.
    Nestico PF; Morganroth J
    Compr Ther; 1987 Apr; 13(4):26-35. PubMed ID: 3105950
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of newer antiarrhythmic drugs in the management of patients with ventricular arrhythmias.
    Cain ME
    Angiology; 1988 Jul; 39(7 Pt 2):668-83. PubMed ID: 3044200
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of procainamide and mexiletine in prevention of ventricular arrhythmias after acute myocardial infarction.
    Campbell RW; Dolder MA; Prescott LF; Talbot RG; Murray A; Julian DG
    Lancet; 1975 Jun; 1(7919):1257-60. PubMed ID: 48894
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intolerance and ineffectiveness of mexiletine in patients with serious ventricular arrhythmias.
    Poole JE; Werner JA; Bardy GH; Graham EL; Pulaski WP; Fahrenbruch CE; Greene HL
    Am Heart J; 1986 Aug; 112(2):322-6. PubMed ID: 3739884
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative efficacy and safety of oral mexiletine and quinidine in benign or potentially lethal ventricular arrhythmias.
    Morganroth J
    Am J Cardiol; 1987 Dec; 60(16):1276-81. PubMed ID: 3318368
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative cost-effectiveness analysis of quinidine, procainamide and mexiletine.
    Podrid PJ; Kowey PR; Frishman WH; Arnold RJ; Kaniecki DJ; Beck JR; Beshansky JR
    Am J Cardiol; 1991 Dec; 68(17):1662-7. PubMed ID: 1836102
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New antiarrhythmic drugs: tocainide, mexiletine, flecainide, encainide, and amiodarone.
    Kreeger RW; Hammill SC
    Mayo Clin Proc; 1987 Nov; 62(11):1033-50. PubMed ID: 3118116
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.